Pharmaceutical Technology

MARCH 10, 2023

The pharmaceutical freeze-drying systems market is expected to be driven by the integration of smarter technologies in lyophilisation methods such as electron microscopy, biochemistry, and advancement in surgeries.

Manufacturing 147

Manufacturing Production Containment Antibody 147

FDA Law Blog

AUGUST 21, 2023

as non-prescription drugs) directly to walk-in customers or in face-to-face transactions by direct sales must self-certify with DEA that their employees have been trained on SCLP sales requirements. Regulated sellers must renew their self-certification annually for each place of business where they sell SCLPs. 21 U.S.C. §

Pharmacy 52

Pharmacy Regulation Sales Production 52

Delveinsight

OCTOBER 1, 2021

There are several therapies in the market to address the Myasthenia Gravis burden, and many companies are still working on their drug candidates to cope with Myasthenia Gravis. The current Myasthenia Gravis therapeutics market has many FDA-approved drugs for the treatment of Myasthenia Gravis. Myasthenia Gravis Approved Therapies.

Marketing 85

Marketing Antibody Drugs Sales 85

XTalks

MARCH 1, 2021

Anti-inflammatory drugs like Restasis and Xiidra are popular treatment options for the condition, but will the emergence of mask-associated dry eye bolster their sales? But if you thought the growing number of patients presenting with mask-associated dry eye would mean higher sales for Restasis, think again.

Sales 119

Sales Drugs Life Science Containment 119

FDA Law Blog

OCTOBER 5, 2023

Earlier this year, DOJ’s CPB issued its own voluntary disclosure policy , which applies more broadly to potential criminal violations “involving the manufacture, distribution, sale, or marketing of products,” as well as “misconduct involving failures to report to, or misrepresentations to” regulators.

Regulation 59

Regulation Compliance Containment Sales 59

Pharma in Brief

APRIL 13, 2021

The Food and Drug Regulations ( FDR ) have been amended to allow for continued expedited review of COVID-19 drugs (including vaccines) while transitioning to authorizations by way of a full notice of compliance ( NOC ) under the FDR. Health Canada has also published a guidance document that contains additional information for drug sponsors.

Regulation 52

Regulation Drugs Vaccination Vaccine 52

The Pharma Data

DECEMBER 10, 2020

The ADSs have been approved for listing on the Nasdaq Global Select Market and are expected to begin trading on December 11, 2020 under the ticker symbol “NBTX.” The Company’s ordinary shares are listed on the regulated market of Euronext Paris under the ticker symbol “NANO.”.

Marketing 52

Marketing Regulation Sales Containment 52

The Pharma Data

JANUARY 24, 2021

million through the issuance of an aggregate 15,455,960 shares of its common stock and warrants to purchase up to an aggregate of 7,727,980 shares of common stock, at a purchase price of $1.294 per share of common stock and associated warrant in a private placement priced at-the-market under Nasdaq rules. H.C. .

Marketing 40

Marketing Production Sales Containment 40

The Pharma Data

DECEMBER 20, 2020

The portfolio generated FY2019 net sales of approximately $109.5 million USD, driven by strong sales of cardiovascular products such as Ebrantil ®. This sale will further sharpen Takeda’s focus and resources in fast tracking innovation in China, and the Emerging Markets. billion ($2.3 billion USD).

Sales 40

Sales Production Marketing Containment 40

FDA Law Blog

MARCH 5, 2024

Last November, Florida went further by introducing a bill to prohibit the manufacture, sale, and distribution of cell-cultured meat entirely. Many states have proposed but failed to enact legislation regulating the labeling of APPs, in some cases due to concerns of potential legal challenges based on federal preemption claims.

Protein 59

Protein Production DNA Containment 59

The Pharma Data

APRIL 28, 2021

This document contains statements that are, or may be deemed to be, “forward-looking statements”. Forward-looking statements give the Group’s current expectations or forecasts of future events.

Sales 52

Sales Regulation Production Containment 52

The Pharma Data

OCTOBER 19, 2020

(OTCQB: BRSF ), a neurology-focused medical device and software company, today announced the appointment of Stuart Bernstein as Vice President of Marketing. In this role, Bernstein will be responsible for Brain Scientific’s overall marketing strategy and efforts to strengthen the company’s market position.

Marketing 40

Marketing Engineer Production Containment 40

XTalks

JULY 27, 2022

Pink Sauce, a product created and marketed by a woman who goes by Chef Pii on TikTok, has gone viral for all the wrong reasons. Yet over the past few weeks, she’s faced numerous questions about Pink Sauce’s ingredients, packaging and marketing, prompting a social media-based food scandal.

FDA Approval 98

FDA Approval Packaging Packaging Production 98

Camargo

NOVEMBER 11, 2020

When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.

Development 242

Development Bioequivalency Generic Drugs Production 242

The Pharma Data

JANUARY 17, 2021

Genus’s worldwide sales are made in over 80 countries under the trademarks ‘ABS’ (dairy and beef cattle) and ‘PIC’ (pigs) and comprise semen, embryos and breeding animals with superior genetics to those animals currently in farms. This announcement is available on the Genus website www.genusplc.com.

Containment 52

Containment Genetics Gene Editing Production 52

Drug Discovery World

FEBRUARY 1, 2023

It is estimated that there will be 340,000 medicinal cannabis users in Europe in 2022 alone, and the overall market is estiated to grow over 500% over the next three years – with the market value in Germany alone poised to hit over €7 billion by 2027 1. Only with more evidence-backed indications will the medicinal market boom.

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Trials 52

Pharma in Brief

JANUARY 9, 2022

These policy initiatives included reforms to the Patented Medicine Prices Review Board ( PMPRB ), the Patented Medicines (Notice of Compliance Regulations) ( PM(NOC) Regulations ), the Patent Rules , and other regulatory matters at Health Canada. Proposed amendments to the PM(NOC) Regulations were also introduced in 2021.

Regulation 52

Regulation Manufacturing Medicine Drugs 52

XTalks

JANUARY 25, 2023

Related: Baby Food Safety Act of 2021: Why Didn’t FDA Regulate Heavy Metals Sooner? Abbott denied its formula contained the bacteria following the results of routine testing it conducts before the formula is distributed, saying in a statement that its focus “has, is and always will be to ensure safe food for families.”

Bacteria 52

Bacteria Contamination Production Regulation 52

The Pharma Data

MAY 15, 2023

Sandoz is a pioneer and market leader in biosimilars and this partnership with Just – Evotec Biologics comes shortly after the company announced increased investments in its Holzkirchen site in Germany to create a core Biopharma Technical Development hub supporting future biosimilar growth. Source link: [link]

Manufacturing 40

Manufacturing Development Production Containment 40

Drug Discovery World

AUGUST 3, 2023

Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due to the regulations relating to the substance. For example, the FDA has not approved a marketing application for cannabis for the treatment of any disease or condition to date 1.

Medicine 52

Medicine Scientist Production Regulation 52

Camargo

FEBRUARY 16, 2021

The Orphan Drug Act defines a rare disease or condition as one (a) which affects less than 200,000 persons in the US or (b) for which there is no reasonable expectation that the cost of developing a drug and making it available in the US will be recovered from sales in the US. Waiver of the marketing application user fee.

Production 130

Production Drugs Marketing In-Vitro 130

XTalks

MAY 24, 2023

The conflict involves the naming rights to “Manuka honey,” a product whose potential health benefits and significant price markup have made it a highly sought-after commodity in the international market. There are also high export costs associated with packaging, exporting and distributing the honey to international markets.

Production 97

Production Packaging Packaging Containment 97

The Pharma Data

OCTOBER 21, 2020

This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (EU) No 596/2014. Abcam’s ordinary shares are admitted to trading on the AIM market of the London Stock Exchange under the symbol “ABC.” This press release contains forward-looking statements. LONDON, Oct. Forward Looking Statements.

Containment 40

Containment Regulation Marketing Sales 40

The Pharma Data

MAY 15, 2021

Sam Hansen is a pen name used for marketing purposes and to protect the author’s identity. Please read the CLICKBANK client contract and all accompanying CLICKBANK policies to ensure your compliance with all applicable policies, rules and regulations. CLICKBANK® is a registered trademark of Click Sales, Inc.,

Production 52

Production Compliance Regulation Doctors 52

The Pharma Data

MAY 14, 2021

Brad Cameron is a pen name used for marketing purposes and to protect the author’s identity. Please read the CLICKBANK client contract and all accompanying CLICKBANK policies to ensure your compliance with all applicable policies, rules and regulations. CLICKBANK® is a registered trademark of Click Sales, Inc.,

Production 52

Production Compliance Regulation Doctors 52

The Pharma Data

MAY 8, 2021

The Sandoz division has a leading global portfolio with eight marketed biosimilars and a further 15-plus in various stages of development. This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Disclaimer. About Sandoz.

Clinical Development 52

Clinical Development Medicine Development Containment 52

The Pharma Data

MAY 15, 2023

Before joining EMMI Group as CEO, he was a Member of the Executive Board and Head of the Marketing Department at Migros-Genossenschafts-Bund. He holds a Master degree in Marketing and Trade from the University of St. Urs Riedener, was CEO of Swiss consumer goods company EMMI Group between 2008 and 2022. Gallen (HSG), Switzerland.

Sales 40

Sales Production Doctors Doctor 40

Intouch Solutions

APRIL 11, 2024

Precision engagement is a data-driven approach developed for marketing and sales needs. Facilitating cost containment and expediting the content approval process in accordance with regulatory compliance. So, what is precision engagement? It uses customer insights to deliver personalized experiences.

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

The Pharma Data

JANUARY 19, 2021

The company’s common shares are listed on the Euronext Growth Paris market (Ticker: ALBPS -ISIN: FR0012816825). This press release contains forward-looking statements. PARIS and CAMBRIDGE, Mass., The company is based in Paris, France, and Cambridge, Massachusetts. Disclaimer.

Regulation 52

Regulation Containment Development Clinical Trials 52

Pharma in Brief

JANUARY 24, 2021

In addition to evolving public health measures related to the pandemic, governments also advanced major policy initiatives, such as reforms to the Patented Medicines Price Regulation Board ( PMPRB ) and other regulatory matters at Health Canada. As we reported, in 2019, the government amended the PMPRB’s Patented Medicines Regulations.

Life Science 52

Life Science Regulation Medicine Drugs 52

The Pharma Data

MARCH 30, 2021

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. These targeted drugs bind to markers or proteins over-expressed by certain tumors, or tumor-associated tissue, such as stroma. Disclaimer. Source link:[link].

Protein 52

Protein Licensing Licensing Containment 52

The Pharma Data

JANUARY 14, 2021

Mr. Levine’s experience in global manufacturing and distribution of regulated healthcare products will be instrumental in the final development of CoviSafe and the establishment of Therma Bright’s manufacturing, logistics and distribution platforms for CoviSafe. a) and 5.7(a)

Manufacturing 52

Manufacturing Sales Production Compliance 52

Camargo

MARCH 25, 2021

This report should contain several pieces of information: The estimated population in the US with the rare disease or condition for which the product was approved (both the overall population and the population aged 0 through 18 years). Sources: CFR – Code of Federal Regulations Title 21. Author: Marissa Berry, PhD, RAC.

Production 130

Production Drugs In-Vitro Containment 130

The Pharma Data

SEPTEMBER 17, 2020

Amgen Forward Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.

Antibody 52

Antibody Manufacturing Production Sales 52

XTalks

NOVEMBER 9, 2023

Since its approval in May 2022, Mounjaro sales have hit $1.4 In the first half of 2023, sales of Ozempic and Wegovy rose by 58 percent and 363 percent, respectively. Zepbound contains mimetics of the GLP-1 and GIP hormones that regulate appetite and blood sugar. billion in just one year and a quarter. billion for Novo.

FDA Approval 59

FDA Approval Manufacturing Drugs Pharmacy 59

The Pharma Data

JANUARY 12, 2021

Vapotherm intends to use this website as a means of disclosing material, non-public information and for complying with Vapotherm’s disclosure obligations under Regulation FD. The information contained on, or that may be accessed through, Vapotherm’s website is not incorporated by reference into, and is not a part of, this document.

Containment 52

Containment Production Marketing Development 52

XTalks

JUNE 27, 2023

Gray market production/theft/diversion: Unregistered or unauthorized products are illicitly sold, bypassing legitimate distribution channels. This can be particularly problematic for individuals with food intolerances, as fraudulent food products may contain undisclosed ingredients that can trigger allergic reactions.

Production 97

Production Branding Manufacturing Packaging 97